BDNF and depressive symptom measurement: A prevailing view in the field is that ketamine restores the functional integrity of neural circuits that are compromised in depression through a synaptogenic process that is triggered by the rapid activity-dependent release of brain-derived neurotrophic factor (BDNF) [1].